About 2018-02-23T05:42:37+00:00

Lantern’s Core Operational Strength

  • Precision.

  • Speed.

  • Cost Effective.

  • Technology and Data Driven.

Lantern Pharma is reinventing the cancer drug development process by tailoring multiple promising precision drug programs to the right cancer patients using advanced genomics and artificial intelligence (AI) with significantly reduced cost and time. Lantern has in-licensed, validated, de-risked clinical stage drugs that are discontinued for development. Lantern identifies genetic signatures or molecular markers for the patient response to the drug and further validates by conducting small, focused phase 2 clinical trials to greatly increase the value of each drug, thereby creating multiple exit points for each drug.


RADR V 3.0™ – Integrated Data Analytics, Experimental Biology and Machine Learning based Platform for Patient Genetic Profiling for Drug Response Prediction.

Meet Our Team

Strong scientific and business team with expertise in pharmaceutical development.

Management Team

Arun k Asaithambi,Co-Founder & CEO
Dr. Arun Asaithambi is CEO of Dallas based Lantern Pharma Inc, Genomics & AI-based biotech company developing precision cancer…
Gregory Tobin,Chief Science Officer
Dr. Tobin’s primary research interests include the development of vaccines, immunotherapeutics, and small molecules for the treatment of cancer.
Jeff Thomas,Chief Operating Officer
Mr. Thomas has been actively engaged with Lantern Pharma for the past 2 and half years and has served as COO since March 2017. Prior joining Lantern his 25+ year career included senior-level positions in sectors including public accounting, entertainment, and private investment.
Peter Nara,Chief Business Officer
Dr. Nara is the President and Chairman of the Board of Biological Mimetics have 18 years of experience in successful co-founding and developing the discovery biotechnology company.

Scientific and Strategic Advisor

Jean Phillipe VertProfessor at École normale supérieure
Dave CoppsFounder and CEO, Brainspace Corp, a Cyxtera Business
Panna SharmaCEO & President of Cancer Genetics, Inc.
Anand AsaithambiCo-Founder and CEO at Intuition Systems
Arul ChinnaiyanProfessor of Pathology, HHMI University of Michigan
Vasant HonavarSenior Artificial Intelligence, Machine Learning, Data Science & Informatics Researcher, Professor
Alex TreeceDirector, The University of Texas at Dallas
Jim MontgomeryVice President, Analytics at Integra Connect